The shares of Allergan plc (NYSE:AGN) has been pegged with a rating of Buy by Guggenheim in its latest research note that was published on October 9th, 2018. Guggenheim wasn’t the only research firm that published a report of Allergan plc, with other equities research analysts also giving their opinion on the stock. Citigroup advised investors in its research note published on April 24th, 2018, to Buy the AGN stock while also putting a $200 price target. The stock had earned Outperform rating from Evercore ISI when it published its report on April 23rd, 2018. The stock was given Hold rating by Stifel in its report released on April 17th, 2018, the day when the price target on the stock was placed at $192. SunTrust was of a view that AGN is Buy in its latest report on February 23rd, 2018 while giving it a price target of $200. Leerink Partners thinks that AGN is worth Outperform rating. This was contained in the firm’s report on February 7th, 2018 in which the stock’s price target was also moved to $242.
Amongst the analysts that rated the stock, 0 have recommended investors to sell it, 6 believe it has the potential for further growth, thus rating it as Hold while 7 advised investors to purchase the stock. The consensus currently stands at a Hold while its average price target is $210.06. The price of the stock the last time has raised by 7.84% from its Week high price while it is raised higher than its 52-Week low price. A look at the stock’s other technical shows that its 14-day RSI now stands at 35.69.
The shares of the company dipped by -2.59% during the trading session on Tuesday, reaching a low of $153.48 while ending the day at $154.00. During the trading session, a total of 4.03 million shares were traded which represents a -88.45% decline from the average session volume which is 2.14M shares. AGN had ended its last session trading at 158.09. Allergan plc currently has a market cap of $52.21B while its P/E earnings growth sits at 3.26, with a beta of 1.30. Allergan plc debt-to-equity ratio currently stands at 0.33, while its quick ratio hovers at 0.80. AGN 52-week low price stands at $142.81 while its 52-week high price is $197.00.
The company in its last quarterly report recorded $4.25 earnings per share which is above the $4.04 predicted by most analysts. The Allergan plc generated $3,911.40 million in revenue during the last quarter, which is slightly higher than the $3,885.38 million predicted by analysts. In the second quarter last year, the firm recorded $4.42 earnings per share. Compared to the same quarter last year, the firm’s revenue was down by -4%. Allergan plc has the potential to record -0.58 EPS for the current fiscal year, according to equities analysts.
Investment analysts at Dougherty & Company published a research note on June 28th, 2018 where it informed investors and clients that Lattice Semiconductor Corporation (NASDAQ:LSCC) is now rated as Buy. Their price target on the stock stands at $10. Citigroup also rated LSCC as Resumed on April 24th, 2018, with its price target of $84 suggesting that LSCC could surge by 18.63% from its current share price. Even though the stock has been trading at $6.47/share, analysts expect it to surge higher by 0.62% to reach $8.00/share. It started the day trading at $6.595 and traded between $6.31 and $6.51 throughout the trading session.
A look at its technical shows that LSCC’s 50-day SMA is 6.82 while its 200-day SMA stands at 6.53. The company’s average trading volume currently stands at 1.09M shares, which means that the short-interest ratio is just 2.18 days. Over the past seven days, the company moved, with its shift of 14.41%. Looking further, the stock has dropped -20.51% over the past 90 days while it gained 8.14% over the last six months.
The change in the stock’s fortunes has led to several institutional investors altering their holdings of the stock. T Rowe Price Associates Inc bought more LSCC shares, increasing its portfolio by +15.57% during the last quarter. This move now sees T Rowe Price Associates Inc purchasing 2,199,032 shares in the last quarter, thus it now holds 16,323,258 shares of LSCC, with a total valuation of $98,102,781. Columbia Management Investment Ad meanwhile sold more LSCC shares in the recently filed quarter, changing its stake to $88,033,987 worth of shares. The Vanguard Group Inc followed the path by increasing its LSCC portfolio by +8.84% in the quarter. This means that The Vanguard Group Inc bought 897,833 shares in the last quarter and now controls 11,050,091 shares of the LSCC stock, with the valuation hitting $66,411,047.
Similarly, BlackRock Fund Advisors increased its Lattice Semiconductor Corporation shares by +5.28% during the recently filed quarter. After buying 374,429 shares in the last quarter, the firm now controls 7,468,168 shares of Lattice Semiconductor Corporation which are valued at $44,883,690. In the same vein, Goldman Sachs Asset Management LP increased its Lattice Semiconductor Corporation shares by during the most recent reported quarter. The firm bought 60,590 shares during the quarter which increased its stakes to 5,636,984 shares and is now valued at $33,878,274. Following these latest developments, around 0.80% of Lattice Semiconductor Corporation stocks are owned by institutional investors and hedge funds.